Aug 18 - Nov 8
HCI Funding Opportunities Listserv – 08-18-2025 Digest
Extramural Funding
Below is the 8/18/2025 digest of HCI/Cancer-related funding opportunities provided by Kelly Clark, Administrative GCO II at HCI.
You may find information about internal funding opportunities offered through programs at HCI on Pulse here.
This web page with standard NIH grant application due dates may also be helpful.
If you wish to be removed from the HCI funding opportunity email list or know someone who would like to be added, please email kelly.clark@hci.utah.edu.
---
| Sponsor | Program Title/Link | Award Amount | Application Due Date | Description |
| Pfizer, Inc. | PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer | $350,000 | August 21, 2025 | This opportunity focuses on enhancing healthcare professional knowledge in biomarker testing, safety, and efficacy of PARP inhibitor combinations for metastatic prostate cancer. Key areas include guideline-based testing, clinical data interpretation, side effect management, therapy sequencing, and multidisciplinary approaches to optimize patient outcomes. |
| United States Department of Defense (DOD) | DoD Prostate Cancer, Idea Development Award | $1,200,000 | September 2, 2025 | The FY25 PCRP Idea Development Award intends to support new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to the PCRP mission. |
| American Society of Clinical Oncology (ASCO) | Global Oncology Young Investigator Award (GO YIA) | $50,000 | September 12, 2025 | The Global Oncology Young Investigator Award (GO YIA) provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation of researchers to address global health needs. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. |
| Melanoma Research Alliance (MRA) | Team Science Awards | $900,000 | September 25, 2025 | Team Science Awards are designed to foster a collaborative research process and promote transformational melanoma research advances with the potential for rapid clinical translation. Evidence of prior collaboration among team members is encouraged, but not required. |
| Melanoma Research Alliance (MRA) | Team Science Academic-Industry Partnership Award | $900,000 | September 25, 2025 | The Academic-Industry Partnership Award (for Teams) is designed to enhance translational research by extending academic capabilities to clinical investigations and to facilitate interactions between the academic and industrial research sectors. These awards will be co-funded by MRA and an industry partner whose involvement is essential to the project. |
| Melanoma Research Alliance (MRA) | Young Investigator Awards | $255,000 | September 30, 2025 | Young Investigator Awards aim to attract early career faculty with original ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma research leaders. Awardees will be provided funding to accomplish innovative and original, preclinical, translational, and/or early clinical research projects. |
| Life Sciences Research Foundation | LSRF Award | See call for details | October 1, 2025 | We receive about 750 applications each year and are able to make 18-27 awards annually. The number of awards depends entirely on our fundraising efforts that year. LSRF does not have an endowment or pool of funds. Each year we seek support for our current group of finalists. |
| CureSearch for Children's Cancer | Catapult Award Program | $2,500,000 | October 7, 2025 | Our Catapult Award program aims to accelerate the development of novel, innovative, less-toxic treatments for children with cancer. The goal of the Catapult Award is to overcome barriers to pediatric cancer drug development by providing meaningful funding in order to advance the development of promising oncology research out of the lab and into clinical trials. |
| National Organization for Rare Disorders, Inc. (NORD) | Rare Disease Research Grant Program: Appendix Cancer and Pseudomyxoma Peritonei | $50,000 | October 12, 2025 | NORD, with funding from NORD member patient organization, the Appendix Cancer/Pseudomyxoma Peritonei Research Foundation, is accepting applications for grants for scientific and/or clinical studies related to Appendix Cancer/Pseudomyxoma Peritonei (ACPMP). |
| World Cancer Research Fund (WCRF) International | INSPIRE Research Challenge | See call for details | November 4, 2025 | The Inspire Research Challenge will prioritise innovative, bold, and creative proposals with the potential to catalyse rapid and impactful advances in cancer prevention, treatment and survivorship. Proposals should address modifiable factors including both lifestyle, such as diet, nutrition, physical activity, and environmental factors such as pollution/contaminants and pathogens. |
| Alex’s Lemonade Stand Foundation (ALSF) | Crazy 8 Pediatric Brain Tumors Grant | $5,000,000 | November 5, 2025 | This ALSF Crazy 8 RFA focuses on developing and enhancing pediatric brain tumor treatments. The focus must be on pediatric/adolescent brain tumors and should be a consortium of two or more institutions with different areas of research collaborating to integrate their expertise. |
| Melanoma Research Alliance (MRA) | Pilot Award | $100,000 | November 6, 2025 | Pilot Awards support senior investigators who propose potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such "high-risk, high-reward" projects are important to establish proof-of-concept, which may then leverage additional funding through more traditional avenues. |
| Gateway for Cancer Research | Gateway Traditional Grant Program | Advancing Patient-Centered Cancer Clinical Trials | $1,500,000 | November 7, 2025 | Gateway funds Phase I and II patient-centered cancer clinical trials that have the potential to shift the paradigm for standard of care. We strive to fund treatment-based studies at the bedside, including all types of cancers. |
| Gateway for Cancer Research | GFCR Integrative Program | Integrative Oncology for Enhanced Cancer Care | See call for details | November 7, 2025 | Gateway focuses on funding integrative oncology research that pairs conventional therapies with evidence-based, complementary therapies to manage symptoms and side effects from treatment. This also aims to increase quality of life during treatment. |